Role of Checkpoint Inhibition in Localized Bladder Cancer

Slides:

Advertisements

Similar presentations

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Advertisements

Global Trends in Testicular Cancer Incidence and Mortality

Volume 64, Issue 4, Pages (October 2013)

European Urology Oncology

Yair Lotan, Peter C. Black, Laura Caba, Sam S. Chang, Michael S

Volume 53, Issue 5, Pages (May 2008)

Ashish M. Kamat, Sima Porten European Urology

Volume 73, Issue 5, Pages (May 2018)

Volume 68, Issue 1, Pages (July 2015)

Prostate Cancer Epidemic in Sight?

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration- resistant Prostate Cancer in the Era of Precision Oncology Philipp.

European Urology Oncology

European Urology Oncology

Bladder Cancer: A Major Public Health Issue

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

Elizabeth K. Bancroft, Rosalind A. Eeles

Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis Mohamad B. Sonbol, Belal Firwana, Talal.

Prostate Cancer Detection: A View of the Future

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 69, Issue 3, Pages (March 2016)

Volume 69, Issue 4, Pages (April 2016)

European Urology Oncology

Counselling the Prostate Cancer Patient

Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients Timo F.W. Soeterik,

Prostate Cancer Epidemic in Sight?

Stephen B. Williams, Ashish M

Volume 70, Issue 1, Pages e27-e28 (July 2016)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery

Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,

The Economic Costs of Overactive Bladder in Germany

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

In This Issue Cell Volume 158, Issue 5, (August 2014)

Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography Andrew.

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Testicular Cancer Variations in Time and Space in Europe

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer Amar U. Kishan, Rahul.

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer Felix Preisser, Michele Marchioni, Sebastiano.

European Urology Oncology

European Urology is “Your” Journal

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

The Cost to Medicare of Bladder Cancer Care

Pembrolizumab-Induced Encephalopathy: A Review of Neurological Toxicities with Immune Checkpoint Inhibitors Sophie Feng, M.B.B.S., Jermaine Coward, PhD,

The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy Neal Patel, Eliza Cricco-Lizza,

Economic Burden of Bladder Cancer Across the European Union

Helping patients make informed decisions

European Urology Oncology

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Beyond Skeletal-Related Events

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

European Urology Oncology

European Urology Oncology

European Lung Cancer Conference (ELCC) 2016 Organisation

Guru Sonpavde, MD, Teresa G. Hayes, MD Mayo Clinic Proceedings

Jan Roigas European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

European Urology Oncology

Volume 51, Issue 5, Pages (May 2007)

Maximilian Burger, Ashish M. Kamat, David McConkey

How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder? Shahrokh Shariat, Paolo Gontero, James.

Morgan Rouprêt, Per-Uno Malmstrom, Peter Black

Presentation transcript:

Role of Checkpoint Inhibition in Localized Bladder Cancer Noah M. Hahn, Andrea Necchi, Yohann Loriot, Thomas Powles, Elizabeth R. Plimack, Guru Sonpavde, Morgan Roupret, Ashish M. Kamat European Urology Oncology Volume 1, Issue 3, Pages 190-198 (August 2018) DOI: 10.1016/j.euo.2018.05.002 Copyright © 2018 Terms and Conditions

Fig. 1 CONSORT diagram of the inclusion and exclusion process for articles. CPI=checkpoint inhibitor. European Urology Oncology 2018 1, 190-198DOI: (10.1016/j.euo.2018.05.002) Copyright © 2018 Terms and Conditions

Fig. 2 Immunocompetent preclinical model systems for investigation of checkpoint inhibitors for localized bladder cancer. (A) BBN carcinogen-induced murine model. (B) MNU carcinogen-induced rat model. (C) MB49 syngeneic orthotopic murine model. BBN=N-butyl-N-(4-hydroxybutyl)nitrosamine; MNU=N-methyl-N-nitrosurea. European Urology Oncology 2018 1, 190-198DOI: (10.1016/j.euo.2018.05.002) Copyright © 2018 Terms and Conditions